NPDC1
(Neural Proliferation, Differentiation and Control, 1 (NPDC1))
Origine
Humain
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB)
Attributs du produit
This is a synthetic peptide designed for use in combination with anti-NPDC1 antibody (Catalog #: ARP47153_T100). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
Each Investigator should determine their own optimal working dilution for specific applications.
Restrictions
For Research Use only
Format
Lyophilized
Reconstitution
Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
Concentration
1 mg/mL
Buffer
Final peptide concentration is 1 mg/mL in PBS.
Conseil sur la manipulation
Avoid repeated freeze-thaw cycles.
Stock
-20 °C
Stockage commentaire
For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
Antigène
NPDC1
(Neural Proliferation, Differentiation and Control, 1 (NPDC1))
Synonymes
AI314472 Peptide, NPDC-1 Peptide, CAB Peptide, CAB- Peptide, CAB-1 Peptide, CAB1 Peptide, neural proliferation, differentiation and control, 1, gene 1 L homeolog Peptide, neural proliferation, differentiation and control 1 Peptide, neural proliferation, differentiation and control, 1 Peptide, npdc1.1.L Peptide, Npdc1 Peptide, NPDC1 Peptide
Sujet
NPDC1 suppresses oncogenic transformation in neural and non-neural cells and down-regulates neural cell proliferation. It might be involved in transcriptional regulation.
Alias Symbols: CAB, CAB-, CAB-1, CAB1, DKFZP586J0523, NPDC-1
Protein Interaction Partner: CCND1,CCND2,CCND3,CDK2,E2F1,HNRNPK,KRTAP4-12,MADD,MDFI,NPDC1,PLSCR1,TFDP1,CCND1,CCND2,CCND3,CDK2,E2F1,HNRNPK,KRTAP4-12,MDFI,PLSCR1,TFDP1